about
Genetic and epigenetic alterations in pancreatic carcinogenesisAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomaMicroRNA miR-155 is a biomarker of early pancreatic neoplasiaHow Grim is Pancreatic Cancer?Deciphering the role of hedgehog signaling in pancreatic cancerScreening for pancreatic cancer in familial high-risk individuals: A systematic reviewEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerMonitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopyDeciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaPancreatic cancer: yesterday, today and tomorrow.In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Imaging pancreatic cancer using bioconjugated InP quantum dots.Multifunctional Nanoparticles as Biocompatible Targeted Probes for Human Cancer Diagnosis and TherapyIdentification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signalingAdjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathwaysManagement of mucinous cystic neoplasms of the pancreas.Management of pancreatic cancer: current status and future directionsA genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreasEffects of integrin-targeted photodynamic therapy on pancreatic carcinoma cellGNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.Aberrant signaling pathways in pancreatic cancer: a two compartment view.Promoter Hypermethylation and Decreased Expression of Syncytin-1 in Pancreatic AdenocarcinomasHIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicityPlasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas.Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms.Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis.Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression.Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinomaIntraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.Limitations in improving detection of pancreatic adenocarcinoma.Histopathologic assessment of pancreatic cancer: does one size fit all?
P2860
Q24598655-F8C83799-4064-4286-8618-3A1F77C0A797Q24627680-C1BE11B2-43FF-48DB-8C23-AD970CCFD4E9Q24649254-1F0E37CB-4A02-4C8F-A5A1-06E75351E32DQ26740598-79B4C2A5-7E0B-4ABC-8B86-BA649CA67112Q26747103-9891FF62-4F96-4C22-86CA-178ACA38180EQ26801172-03709C39-640C-42F0-A109-04AF836D9E00Q27010209-96E7A3B8-9AED-4BFE-8016-BDA93C2044C7Q27312539-986B432D-7535-4372-B168-8B96E1012CB2Q28079848-70523AE8-46A5-4C01-AD16-78D338A3FA33Q28534618-56A08CD4-C51D-4DBF-A5B1-50F76E7735E7Q30250026-B1200EBB-982C-4F8F-8193-C8DB6D966957Q30501198-2FCDA183-428E-4204-B22A-E0F8B6B8B279Q30504615-C90F2E62-768F-47FF-8A99-100A67AEDF26Q33412483-A826AA67-70B2-411A-9F71-15F3D931BFC1Q33543746-C9FF90C3-4B51-47ED-91A4-659453DD877EQ33588191-334F556F-9C0F-403E-A5A8-7B86C1ECEA91Q33733149-8D318AD9-F9DF-4EFD-9D07-B2DC4D3FE3A7Q33858490-4974C2DA-6985-4937-9560-46B8C0AEEC07Q34093790-9956FEA4-8707-4384-921E-0AEFDB25A5B6Q34185812-DCD0ECBC-47F0-449A-905D-18DA76FD927CQ34385132-0E175398-4B89-4AF9-B2DB-B64B6B4004F8Q34409883-CBEB3733-A2C2-4C9B-A239-9E52B4834D98Q34994302-131EEF93-3F18-4099-9487-DAACEE9729CBQ35024556-7C4CCAA0-3C82-4C9E-BEE8-878ABCA8851AQ35537214-2406A95D-D5ED-4CF0-98EC-FA153DF6DB3AQ35641254-A9766064-4ECE-450B-B655-331DA42D168FQ35660658-32B8E3CD-553B-422A-BF08-FB9D1B6AB61AQ35730945-44F8D5EF-CF40-4BDE-8565-390947EA9D8DQ35832992-9A7D4344-B468-469C-9275-7648CA3E25CBQ36029643-5DE50798-A63B-478C-A794-22017ECB15C3Q36042474-81268CED-523F-4B48-8773-B79E722C13A8Q36152949-E2E7130D-733D-4142-98ED-7531AE691066Q36175078-935F771C-91B9-4590-92AA-4401B28C4CA9Q36426956-9AB4F3A7-B168-49DE-85C9-C7BF89E9FF2EQ36472807-4004714B-C63F-4D15-8894-0F246F059FEBQ37068621-03F4406E-0436-4D59-835F-F187012E23FDQ37073180-7A231BC5-9F61-4059-A428-9F4C58BEF6EBQ37183611-768FEB93-D8D5-42AF-A0CF-07D2691DB4E1Q37515365-704BE834-BE0E-428E-B09A-8A7B8E67960CQ38019895-04300A94-57BC-4945-9E60-D88A521A5556
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Precursors to pancreatic cancer.
@ast
Precursors to pancreatic cancer.
@en
type
label
Precursors to pancreatic cancer.
@ast
Precursors to pancreatic cancer.
@en
prefLabel
Precursors to pancreatic cancer.
@ast
Precursors to pancreatic cancer.
@en
P2860
P1476
Precursors to pancreatic cancer.
@en
P2093
Anirban Maitra
Scott E Kern
P2860
P304
831-49, vi
P356
10.1016/J.GTC.2007.08.012
P577
2007-12-01T00:00:00Z